Arcoma AB (Sweden) Technical Analysis
| ARCOMA Stock | SEK 7.26 0.02 0.28% |
As of the 5th of February, Arcoma AB shows the mean deviation of 1.68, and Risk Adjusted Performance of (0.08). Arcoma AB technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Arcoma AB Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Arcoma, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ArcomaArcoma |
Arcoma AB 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Arcoma AB's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Arcoma AB.
| 11/07/2025 |
| 02/05/2026 |
If you would invest 0.00 in Arcoma AB on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding Arcoma AB or generate 0.0% return on investment in Arcoma AB over 90 days. Arcoma AB is related to or competes with Scibase AB, Biosergen, Iconovo, Luxbright, Neola Medical, Nanologica, and Biovica International. Arcoma AB develops, produces, and provides radiology solutions worldwide More
Arcoma AB Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Arcoma AB's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Arcoma AB upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 9.91 | |||
| Value At Risk | (3.77) | |||
| Potential Upside | 2.87 |
Arcoma AB Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Arcoma AB's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Arcoma AB's standard deviation. In reality, there are many statistical measures that can use Arcoma AB historical prices to predict the future Arcoma AB's volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.41) | |||
| Treynor Ratio | 2.94 |
Arcoma AB February 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | 2.95 | |||
| Mean Deviation | 1.68 | |||
| Coefficient Of Variation | (873.56) | |||
| Standard Deviation | 2.13 | |||
| Variance | 4.56 | |||
| Information Ratio | (0.14) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.41) | |||
| Treynor Ratio | 2.94 | |||
| Maximum Drawdown | 9.91 | |||
| Value At Risk | (3.77) | |||
| Potential Upside | 2.87 | |||
| Skewness | 0.1378 | |||
| Kurtosis | (0.06) |
Arcoma AB Backtested Returns
Arcoma AB secures Sharpe Ratio (or Efficiency) of -0.0312, which signifies that the company had a -0.0312 % return per unit of standard deviation over the last 3 months. Arcoma AB exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Arcoma AB's risk adjusted performance of (0.08), and Mean Deviation of 1.68 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.0865, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Arcoma AB are expected to decrease at a much lower rate. During the bear market, Arcoma AB is likely to outperform the market. At this point, Arcoma AB has a negative expected return of -0.0633%. Please make sure to confirm Arcoma AB's information ratio, as well as the relationship between the potential upside and rate of daily change , to decide if Arcoma AB performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.26 |
Weak reverse predictability
Arcoma AB has weak reverse predictability. Overlapping area represents the amount of predictability between Arcoma AB time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Arcoma AB price movement. The serial correlation of -0.26 indicates that nearly 26.0% of current Arcoma AB price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.26 | |
| Spearman Rank Test | -0.04 | |
| Residual Average | 0.0 | |
| Price Variance | 0.05 |
Arcoma AB technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Arcoma AB Technical Analysis
The output start index for this execution was fifty with a total number of output elements of eleven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Arcoma AB volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Arcoma AB Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Arcoma AB on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Arcoma AB based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Arcoma AB price pattern first instead of the macroeconomic environment surrounding Arcoma AB. By analyzing Arcoma AB's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Arcoma AB's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Arcoma AB specific price patterns or momentum indicators. Please read more on our technical analysis page.
Arcoma AB February 5, 2026 Technical Indicators
Most technical analysis of Arcoma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Arcoma from various momentum indicators to cycle indicators. When you analyze Arcoma charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | 2.95 | |||
| Mean Deviation | 1.68 | |||
| Coefficient Of Variation | (873.56) | |||
| Standard Deviation | 2.13 | |||
| Variance | 4.56 | |||
| Information Ratio | (0.14) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.41) | |||
| Treynor Ratio | 2.94 | |||
| Maximum Drawdown | 9.91 | |||
| Value At Risk | (3.77) | |||
| Potential Upside | 2.87 | |||
| Skewness | 0.1378 | |||
| Kurtosis | (0.06) |
Arcoma AB February 5, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Arcoma stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 232.90 | ||
| Daily Balance Of Power | 0.14 | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 7.31 | ||
| Day Typical Price | 7.29 | ||
| Price Action Indicator | (0.04) |
Complementary Tools for Arcoma Stock analysis
When running Arcoma AB's price analysis, check to measure Arcoma AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcoma AB is operating at the current time. Most of Arcoma AB's value examination focuses on studying past and present price action to predict the probability of Arcoma AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcoma AB's price. Additionally, you may evaluate how the addition of Arcoma AB to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |